{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13(1)"],"submitter":["Li XY"],"pubmed_abstract":["<h4>Background</h4>The self-reported quality of life (QoL) should be carefully listened to in progressive supranuclear palsy (PSP) from the patient-centered perspective. However, there was still a lack of short QoL measurement tool in atypical parkinsonism.<h4>Objective</h4>We aimed to test whether the short Parkinson's Disease Questionnaire-8 (PDQ-8) was effective in assessing QoL in PSP, comparing with Progressive Supranuclear Palsy Quality of Life Scale (PSP-QoL) and Parkinson's Disease Questionnaire-39 (PDQ-39).<h4>Methods</h4>132 patients with clinical diagnosed PSP, including PSP-Richardson syndrome (RS) subtype (n = 71) and PSP-non-RS subtype (n = 61) were recruited for clinical evaluation including QoL assessment. The detailed QoL profiles and possibility of using PDQ-8 were system"],"journal":["Journal of Parkinson's disease"],"pagination":["83-91"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9912724"],"repository":["biostudies-literature"],"pubmed_title":["PDQ-8: A Simplified and Effective Tool Measuring Life Quality in Progressive Supranuclear Palsy."],"pmcid":["PMC9912724"],"pubmed_authors":["Li G","Wu B","Shen B","Sun YM","Wang J","Liang XN","Chen MJ","Yao RX","Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI)","Li XY","Liu FT","Wu JJ","Yang YJ"],"additional_accession":[]},"is_claimable":false,"name":"PDQ-8: A Simplified and Effective Tool Measuring Life Quality in Progressive Supranuclear Palsy.","description":"<h4>Background</h4>The self-reported quality of life (QoL) should be carefully listened to in progressive supranuclear palsy (PSP) from the patient-centered perspective. However, there was still a lack of short QoL measurement tool in atypical parkinsonism.<h4>Objective</h4>We aimed to test whether the short Parkinson's Disease Questionnaire-8 (PDQ-8) was effective in assessing QoL in PSP, comparing with Progressive Supranuclear Palsy Quality of Life Scale (PSP-QoL) and Parkinson's Disease Questionnaire-39 (PDQ-39).<h4>Methods</h4>132 patients with clinical diagnosed PSP, including PSP-Richardson syndrome (RS) subtype (n = 71) and PSP-non-RS subtype (n = 61) were recruited for clinical evaluation including QoL assessment. The detailed QoL profiles and possibility of using PDQ-8 were system","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023","modification":"2025-04-18T15:52:21.696Z","creation":"2025-04-07T02:45:08.933Z"},"accession":"S-EPMC9912724","cross_references":{"pubmed":["36591660"],"doi":["10.3233/JPD-223553"]}}